Local IL-17 production exerts a protective role in murine experimental glomerulonephritis

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Hamour, Sally ^a   Gan, Poh Yi ^b   Pepper, Ruth ^a   Barros, Fernanda Florez ^a   Wang, Hsu Han ^a   O'Sullivan, Kim ^b   Iwakura, Yoichiro ^c   Cook, Terence ^d   Pusey, Charles ^d   Holdsworth, Stephen ^b   Salama, Alan ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 23; MANNOSE RECEPTOR; UREA; IL10 PROTEIN, MOUSE; IL1B PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; EXPERIMENTAL GLOMERULONEPHRITIS; GENE OVEREXPRESSION; GLOMERULAR THROMBOSIS; KIDNEY TUBULE DISORDER; MACROPHAGE; MALE; MAST CELL; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEINURIA; RADIOSENSITIVITY; THROMBOSIS; UREA BLOOD LEVEL; WILD TYPE; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; GENETICS; GLOMERULONEPHRITIS; KIDNEY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; RADIATION TOLERANCE;

ANIMALS; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; INTERLEUKIN-10; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-23; KIDNEY; MICE; MICE, KNOCKOUT; RADIATION TOLERANCE;

EID: 84943329512     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0136238     Document Type: Article

References (48)

1. Xu S, Cao X. Interleukin-17 and its expanding biological functions. Cellular & molecular immunology. 2010;7(3):164-74. Epub 2010/04/13. doi: 10.1038/cmi.2010.21 PMID: 20383173.
2. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology. 2010;129(3):311-21. Epub 2010/04/23. doi: 10.1111/j.1365-2567.2009.03240.x PMID: 20409152; PubMed Central PMCID: PMC2826676.
3. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. NatImmunol. 2005;6(11):1123. PMID: 16200070; ni1254 [pii].
4. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. NatImmunol. 2005;6(11):1133. PMID: 16200068; ni1261 [pii].
5. Ooi JD, Phoon RK, Holdsworth SR, Kitching AR. IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen. JAmSocNephrol. 2009;20(5):980. PMID: 19357249; ASN.2008080891 [pii].
6. Paust HJ, Turner JE, Steinmetz OM, Peters A, Heymann F, Holscher C, et al. The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. JAmSocNephrol. 2009;20(5):969. PMID: 19339380; ASN.2008050556 [pii].
7. Hamour S, Cook T, Iwakura Y, Pusey C, Salama AD. Critical role of IL-17 in accelerated nephrotoxic nephritis. P198 Renal Association; Liverpool, UK 2009.
8. Gan PY, Steinmetz OM, Tan DS, O'Sullivan KM, Ooi JD, Iwakura Y, et al. Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis. J Am Soc Nephrol. 2010;21(6):925-31. Epub 2010/03/20. doi: 10.1681/asn. 2009070763 PMID: 20299361; PubMed Central PMCID: PMC2900960.
9. Yi T, Zhao D, Lin CL, Zhang C, Chen Y, Todorov I, et al. Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood. 2008;112(5):2101-10. Epub 2008/07/04. doi: 10.1182/blood-2007-12-126987 PMID: 18596226; PubMed Central PMCID: PMC2518909.
10. Schnyder-Candrian S, Togbe D, Couillin I, Mercier I, Brombacher F, Quesniaux V, et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med. 2006;203(12):2715-25. Epub 2006/11/15. doi: 10.1084/jem.20061401 PMID: 17101734; PubMed Central PMCID: PMC2118159.
11. Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clinical immunology (Orlando, Fla). 2004;110(1):55-62. Epub 2004/02/14. doi: 10.1016/j.clim.2003.09.013 PMID: 14962796.
12. Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK. Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflammatory bowel diseases. 2006;12(5):382-8. Epub 2006/05/04. PMID: 16670527.
13. O'Connor W Jr., Kamanaka M, Booth CJ, Town T, Nakae S, Iwakura Y, et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol. 2009;10(6):603-9. Epub 2009/05/19. doi: 10.1038/ni.1736 PMID: 19448631; PubMed Central PMCID: PMC2709990.
14. Ke Y, Liu K, Huang GQ, Cui Y, Kaplan HJ, Shao H, et al. Anti-inflammatory role of IL-17 in experimental autoimmune uveitis. Journal of immunology (Baltimore, Md: 1950). 2009;182(5):3183-90. Epub 2009/02/24. doi: 10.4049/jimmunol.0802487 PMID: 19234216; PubMed Central PMCID: PMC3275433.
15. Odobasic D, Gan PY, Summers SA, Semple TJ, Muljadi RC, Iwakura Y, et al. Interleukin-17A promotes early but attenuates established disease in crescentic glomerulonephritis in mice. Am J Pathol. 2011;179(3):1188-98. Epub 2011/07/12. doi: 10.1016/j.ajpath.2011.05.039 PMID: 21741931; PubMed Central PMCID: PMC3157183.
16. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity. 2002;17(3):375. PMID: 12354389; S1074761302003916 [pii].
17. Pang M, Ma L, Gong R, Tolbert E, Mao H, Ponnusamy M, et al. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. Kidney Int. 2010;78(3):257-68. Epub 2010/06/04. doi: 10.1038/ki.2010.154 PMID: 20520592.
18. Lee S, Huen S, Nishio H, Nishio S, Lee HK, Choi BS, et al. Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol. 2011;22(2):317-26. Epub 2011/02/04. doi: 10.1681/asn. 2009060615 PMID: 21289217; PubMed Central PMCID: PMC3029904.
19. Phoon RK, Kitching AR, Odobasic D, Jones LK, Semple TJ, Holdsworth SR. T-bet deficiency attenuates renal injury in experimental crescentic glomerulonephritis. J Am Soc Nephrol. 2008;19(3):477-85. Epub 2008/02/01. doi: 10.1681/asn. 2007030392 PMID: 18235099; PubMed Central PMCID: PMC2391047.
20. Tipping PG, Huang XR, Qi M, Van GY, Tang WW. Crescentic glomerulonephritis in CD4- and CD8-deficient mice. Requirement for CD4 but not CD8 cells. Am J Pathol. 1998;152(6):1541. PMID: 9626058.
21. Holdsworth SR, Neale TJ, Wilson CB. Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum. J Clin Invest. 1981;68(3):686-98. Epub 1981/09/01. PMID: 7276168; PubMed Central PMCID: PMC370850.
22. Gordon S. Alternative activation of macrophages. Nature reviews Immunology. 2003;3(1):23-35. Epub 2003/01/04. doi: 10.1038/nri978 PMID: 12511873.
23. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nature reviews Immunology. 2005;5(12):953-64. Epub 2005/12/03. doi: 10.1038/nri1733 PMID: 16322748.
24. Gan PY, Summers SA, Ooi JD, O'Sullivan KM, Tan DS, Muljadi RC, et al. Mast cells contribute to peripheral tolerance and attenuate autoimmune vasculitis. J Am Soc Nephrol. 2012;23(12):1955-66. Epub 2012/11/10. doi: 10.1681/asn. 2012060572 PMID: 23138486; PubMed Central PMCID: PMC3507370.
25. Lin AM, Rubin CJ, Khandpur R, Wang JY, Riblett M, Yalavarthi S, et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. Journal of immunology (Baltimore, Md: 1950). 2011;187(1):490-500. Epub 2011/05/25. doi: 10.4049/jimmunol.1100123 PMID: 21606249; PubMed Central PMCID: PMC3119764.
26. Kojima S, Ovary Z. Radioresistance of some biologic properties of mouse mast cells. Journal of immunology (Baltimore, Md: 1950). 1974;113(2):673-6. Epub 1974/08/01. PMID: 4858627.
27. Tulone C, Giorgini A, Freeley S, Coughlan A, Robson MG. Transferred antigen-specific T (H) 17 but not T (H) 1 cells induce crescentic glomerulonephritis in mice. Am J Pathol. 2011;179(6):2683-90. Epub 2011/10/11. doi: 10.1016/j.ajpath.2011.08.017 PMID: 21983633; PubMed Central PMCID: PMC3260861.
28. Summers SA, Steinmetz OM, Li M, Kausman JY, Semple T, Edgtton KL, et al. Th1 and Th17 Cells Induce Proliferative Glomerulonephritis. J Am Soc Nephrol. 2009: E pub 2009 Oct. 13. Epub 2009/10/13. ASN.2009030337 [pii] doi: 10.1681/ASN.2009030337 [doi]. PMID: 19820122.
29. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nature reviews Immunology. 2010;10(7):479-89. Epub 2010/06/19. doi: 10.1038/nri2800 PMID: 20559326.
30. Velden J, Paust HJ, Hoxha E, Turner JE, Steinmetz OM, Wolf G, et al. Renal IL-17 expression in human ANCA-associated glomerulonephritis. American journal of physiology Renal physiology. 2012. Epub 2012/03/24. doi: 10.1152/ajprenal.00683.2011 PMID: 22442208.
31. Song C, Luo L, Lei Z, Li B, Liang Z, Liu G, et al. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. JImmunol. 2008;181(9):6117. PMID: 18941201; 181/9/6117 [pii].
32. Tao J, Kamanaka M, Hao J, Hao Z, Jiang X, Craft JE, et al. IL-10 signaling in CD4+ T cells is critical for the pathogenesis of collagen-induced arthritis. Arthritis research & therapy. 2011;13(6):R212. Epub 2011/12/24. doi: 10.1186/ar3545 PMID: 22192790; PubMed Central PMCID: PMC3334665.
33. Hueber AJ, Asquith DL, Miller AM, Reilly J, Kerr S, Leipe J, et al. Mast cells express IL-17A in rheumatoid arthritis synovium. Journal of immunology (Baltimore, Md: 1950). 2010;184(7):3336-40. Epub 2010/03/05. doi: 10.4049/jimmunol.0903566 PMID: 20200272.
34. Farnsworth A, Wotherspoon JS, Dorsch SE. Postirradiation recovery of lymphoid cells in the rat. Transplantation. 1988;46(3):418-25. Epub 1988/09/01. PMID: 2971280.
35. Lu LF, Lind EF, Gondek DC, Bennett KA, Gleeson MW, Pino-Lagos K, et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature. 2006;442(7106):997-1002. Epub 2006/08/22. doi: 10.1038/nature05010 PMID: 16921386
36. Hochegger K, Siebenhaar F, Vielhauer V, Heininger D, Mayadas TN, Mayer G, et al. Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis. European journal of immunology. 2005;35(10):3074-82. Epub 2005/09/24. doi: 10.1002/eji.200526250 PMID: 16180252.
37. Timoshanko JR, Kitching AR, Semple TJ, Tipping PG, Holdsworth SR. A pathogenetic role for mast cells in experimental crescentic glomerulonephritis. J Am Soc Nephrol. 2006;17(1):150-9. Epub 2005/12/02. doi: 10.1681/asn. 2005080799 PMID: 16319187.
38. Kitching AR, Tipping PG, Timoshanko JR, Holdsworth SR. Endogenous interleukin-10 regulates Th1 responses that induce crescentic glomerulonephritis. Kidney Int. 2000;57(2):518-25. Epub 2000/01/29. doi: 10.1046/j.1523-1755.2000.00872.x PMID: 10652028.
39. Grimbaldeston MA, Nakae S, Kalesnikoff J, Tsai M, Galli SJ. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol. 2007;8(10):1095-104. Epub 2007/09/04. doi: 10.1038/ni1503 PMID: 17767162.
40. Chan CY, St John AL, Abraham SN. Mast cell interleukin-10 drives localized tolerance in chronic bladder infection. Immunity. 2013;38(2):349-59. Epub 2013/02/19. doi: 10.1016/j.immuni.2012.10.019 PMID: 23415912; PubMed Central PMCID: PMC3647685.
41. Ishizuka T, Okayama Y, Kobayashi H, Mori M. Interleukin-10 is localized to and released by human lung mast cells. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology. 1999;29(10):1424-32. Epub 1999/10/16. PMID: 10520066.
42. Zhang L, Yuan S, Cheng G, Guo B. Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation. PloS one. 2011;6(12):e28432. Epub 2011/12/14. doi: 10.1371/journal.pone.0028432 PMID: 22163016; PubMed Central PMCID: PMC3232207.
43. Yang M, Deng J, Liu Y, Ko KH, Wang X, Jiao Z, et al. IL-10-Producing Regulatory B10 Cells Ameliorate Collagen-Induced Arthritis via Suppressing Th17 Cell Generation. Am J Pathol. 2012;180(6):2375-85. Epub 2012/04/28. doi: 10.1016/j.ajpath.2012.03.010 PMID: 22538089.
44. Tam FW, Smith J, Karkar AM, Pusey CD, Rees AJ. Interleukin-4 ameliorates experimental glomerulonephritis and up-regulates glomerular gene expression of IL-1 decoy receptor. Kidney Int. 1997;52(5):1224-31. Epub 1997/11/14. PMID: 9350645.
45. Harker JA, Lewis GM, Mack L, Zuniga EI. Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science (New York, NY). 2011;334(6057):825-9. Epub 2011/10/01. doi: 10.1126/science.1208421 PMID: 21960530.
46. Papp KA, Leonardi C, Menter A, Ortonne JP, Krueger JG, Kricorian G, et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. N Engl J Med. 2012;366(13):1181-9. Epub 2012/03/30. doi: 10.1056/NEJMoa1109017 PMID: 22455412.
47. Leonardi C, Matheson R, Zachariae C, Cameron G, Li L, Edson-Heredia E, et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N Engl J Med. 2012;366(13):1190-9. Epub 2012/03/30. doi: 10.1056/NEJMoa1109997 PMID: 22455413.
48. Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PD, et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut. 2012. Epub 2012/05/19. doi: 10. 1136/gutjnl-2011-301668 PMID: 22595313.